Validate K48/K63 ubiquitin chain balance as therapeutic target in ALS
Test whether the balance between K48 (degradative) and K63 (signaling) ubiquitin chains drives UBQLN2-related ALS. If true, restoring this balance should reduce aggregation and improve outcomes.
$500
OPEN
Confidence:
50%
Created: 2026-04-26
Landscape analysis not yet run for this challenge. Run the landscape analyzer to get competitive intelligence.